AKT1 and esophageal cancer: Li et al. report shows that rocuronium bromide could repress PI3K/AKT/mTOR signaling pathway and autophagy to block the CXCL12 expression in CAFs, thereby weakening the cytokines CXCL12-mediated esophageal cancer progression [35].